Improved Synthesis of 2'-deoxy-2'-[18F]fluoro-5-Methyl-1-&bgr;-DArabinofuranosyluracil ([18F]FMAU)

E-ISSN： 1874-4729|4|1|24-30

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.4, Iss.1, 2011-01, pp. : 24-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radiosynthesis of 2'-deoxy-2'-[18F]fluorothymidine ([18F]FT), a Putative PET Agent for Imaging HSV-TK Expression

Current Radiopharmaceuticals, Vol. 2, Iss. 1, 2009-01 ,pp. : 75-82

Bentham Science Publishers

Access to resources Recommend Favorite

? -[¹⁸F]Fluoro Azomycin Arabinoside (? -[¹⁸F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 Tumors

Current Radiopharmaceuticals, Vol. 10, Iss. 2, 2017-08 ,pp. : 93-101

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of Preventives and Therapeutics for Alzheimer's Disease that Inhibit the Formation of &bgr;-Amyloid Fibrils (fA&bgr;), as Well as Destabilize Preformed fA&bgr;

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4357-4375

Bentham Science Publishers

Access to resources Recommend Favorite

Radiosynthesis of 8-Fluoro-3-(4-[18F]Fluorophenyl)-3,4-Dihydro-1-Isoquinolinamine ([18F]FFDI), a Potential PET Radiotracer for the Inducible Nitric Oxide Synthase

Current Radiopharmaceuticals, Vol. 1, Iss. 2, 2008-05 ,pp. : 49-53

Bentham Science Publishers

Access to resources Recommend Favorite

Galantamine-induced improvements in cognitive function are not related to alterations in α₄β₂ nicotinic receptors in early Alzheimer’s disease as measured in vivo by 2-[¹⁸F]Fluoro-A-85380 PET

By Ellis J. Nathan P. Villemagne V. Mulligan R. Saunder T. Young K. Smith C. Welch J. Woodward M. Wesnes K. Savage G. Rowe C.

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 79-91

Springer Publishing Company

Access to resources Recommend Favorite